Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...
A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback